Case File №
#VI-2026-0699
Mix Peptides
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
41 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | D Poor | 9 | 6.7 | 3.3 | 9.1 | 23 Oct 2025 |
| Tirzepatide | E Bad | 20 | 6.6 | 1.4 | 9.7 | 23 Oct 2025 |
| 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | X N/A | 2 | 6.0 | 5.4 | 6.5 | 17 May 2026 |
| Adipotide | X N/A | 1 | 8.2 | 8.2 | 8.2 | 13 Jun 2025 |
| AICAR | X N/A | 2 | 5.7 | 4.6 | 6.7 | 26 Jan 2026 |
| Anastrozole (Arimidex) Raw | X N/A | 1 | 5.0 | 5.0 | 5.0 | 14 Jan 2025 |
| ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | X N/A | 1 | 6.9 | 6.9 | 6.9 | 9 Jun 2025 |
| Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | X N/A | 2 | 6.5 | 4.9 | 8.0 | 26 Jan 2026 |
| Boldenone Undecylenate (EQ) Raw | X N/A | 2 | 7.5 | 5.7 | 9.3 | 20 May 2026 |
| BPC157 10mg + TB500 10mg Blend | X N/A | 1 | 5.8 | 5.8 | 5.8 | 21 May 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 2 | 6.6 | 6.2 | 7.0 | 21 May 2026 |
| Bronchogen | X N/A | 1 | 7.2 | 7.2 | 7.2 | 24 Apr 2025 |
| Cardiogen | X N/A | 2 | 5.8 | 5.5 | 6.0 | 21 May 2026 |
| Cartalax | X N/A | 1 | 5.1 | 5.1 | 5.1 | 11 Jun 2025 |
| Cerebrolysin | X N/A | 1 | 6.7 | 6.7 | 6.7 | 11 Jun 2025 |
| Drostanolone Enanthate (Mast E) Raw | X N/A | 1 | 7.2 | 7.2 | 7.2 | 3 Jun 2025 |
| EPO | X N/A | 2 | 6.0 | 5.2 | 6.7 | 24 May 2026 |
| Estradiol Cypionate | X N/A | 2 | 6.3 | 5.7 | 6.9 | 20 May 2026 |
| FOXO4 | X N/A | 2 | 6.2 | 4.8 | 7.6 | 23 May 2026 |
| GHRP-2 Acetate | X N/A | 2 | 7.2 | 6.5 | 7.8 | 24 May 2026 |
| HCG | X N/A | 1 | 6.2 | 6.2 | 6.2 | 13 Feb 2025 |
| Hyaluronic acid | X N/A | 2 | 6.0 | 5.5 | 6.5 | 21 May 2026 |
| KPV Oral | X N/A | 1 | 4.0 | 3.1 | 3.1 | 6 May 2025 |
| Orforglipron | X N/A | 2 | 6.8 | 6.7 | 7.0 | 26 Jan 2026 |
| Ostarine (MK-2866) | X N/A | 2 | 6.5 | 6.5 | 6.6 | 24 May 2026 |
| Oxytocin Acetate | X N/A | 2 | 6.3 | 5.6 | 7.0 | 23 May 2026 |
| P21 | X N/A | 2 | 6.5 | 6.5 | 6.5 | 17 May 2026 |
| PE 22-28 | X N/A | 1 | 6.4 | 6.4 | 6.4 | 3 Jul 2025 |
| Pinealon | X N/A | 1 | 4.0 | 3.2 | 3.2 | 2 Jul 2025 |
| Proviron (Mesterolone) | X N/A | 2 | 6.9 | 6.8 | 7.0 | 19 Jan 2026 |
| Semax | X N/A | 2 | 4.8 | 3.9 | 5.7 | 24 May 2026 |
| SR9009 | X N/A | 1 | 4.9 | 4.9 | 4.9 | 11 Jun 2025 |
| Super Shred | X N/A | 1 | 8.5 | 8.5 | 8.5 | 21 May 2025 |
| Superdrol | X N/A | 1 | 5.5 | 5.5 | 5.5 | 20 Jun 2025 |
| T4 (Levothyroxine) | X N/A | 2 | 6.6 | 5.0 | 8.2 | 20 May 2026 |
| Thymalin | X N/A | 1 | 7.7 | 7.7 | 7.7 | 2 Jul 2025 |
| Thymosin Alpha-1 | X N/A | 1 | 6.5 | 6.5 | 6.5 | 27 Feb 2025 |
| Tirzepatide Raw | X N/A | 1 | 6.2 | 6.2 | 6.2 | 25 Apr 2025 |
| Trenbolone Acetate | X N/A | 1 | 6.9 | 6.9 | 6.9 | 28 Mar 2025 |
| Trenbolone Enanthate | X N/A | 2 | 8.5 | 7.6 | 9.4 | 26 Jan 2026 |
| YK-11 Raw | X N/A | 2 | 6.8 | 5.8 | 7.9 | 19 Jan 2026 |
Exhibit II
Evidence Log
66 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | Adipotide | 7.7 A | 10mg | 12.4mg | +23.8% | 96.60% | pzit5z | Lab C | Community |
| 25 May 2026 | Cardiogen | 6.4 A | 10mg | 10.1mg | +0.6% | 96.85% | md730s | Lab D | Public |
| 25 May 2026 | Thymosin Alpha-1 | 8.0 A | 30mg | 29.8mg | -0.5% | 97.90% | ursy7i | Lab C | Community |
| 24 May 2026 | GHRP-2 Acetate | 6.6 A | 20mg | 23.0mg | +15.2% | 98.08% | 29iltu | Lab C | Community |
| 24 May 2026 | Tirzepatide | 1.4 E | 30mg | (no batch claim) | 51.1mg | +70.3% | 97.46% | (no batch ID) | No Label / Silver Crimp / Orange Cap |
| 24 May 2026 | Tirzepatide | 4.1 D | 30mg | 33.5mgpackage | 28.1mg | -16.1% | 98.15% | 2025A56-12 | No Label / Silver Crimp / Orange Cap |
| 24 May 2026 | BPC157 5mg + TB500 5mg Blend | 6.2 A | 2mg | 2.2mg | +9.8% | 96.26% | afbvjq | Lab D | Public |
| 24 May 2026 | Trenbolone Enanthate | 7.8 A | 300mg/ml | 271.9mg/ml | -9.4% | 97.08% | 3ubot4 | Lab E | Community |
| 24 May 2026 | AICAR | 4.3 C | 5mg | 5.1mg | +1.6% | 98.88% | x9bp67 | Lab B | Public |
| 24 May 2026 | Retatrutide | 9.1 A | 50mg | 57.4mgpackage | 53.8mg | -6.3% | 99.90% | 2025B510-10 | No Label / Green Crimp / Clear Cap |
| 24 May 2026 | HCG | 7.2 A | 50mg | 56.5mg | +13.1% | 97.79% | 2o1441 | Lab F | Community |
| 24 May 2026 | Pinealon | 5.1 B | 2mg | 2.0mg | -1.6% | 98.79% | 5y3wwb | Lab G | Community |
| 23 May 2026 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 8.6 A | 250mg/ml | 243.1mg/ml | -2.8% | 96.44% | 8m7sbk | Lab D | Community |
| 23 May 2026 | Cerebrolysin | 9.1 A | 20mg | 23.6mg | +18.0% | 96.98% | v8dl3m | Lab G | Public |
| 23 May 2026 | Estradiol Cypionate | 5.1 B | 200mg/ml | 183.0mg/ml | -8.5% | 98.82% | 2nvbcj | Lab E | Public |
| 23 May 2026 | Ostarine (MK-2866) | 6.9 A | 100mg | 113.5mg | +13.5% | 95.80% | mxc4p6 | Lab G | Community |
| 23 May 2026 | SR9009 | 4.0 C | 10mg | 11.1mg | +11.2% | 99.42% | 3g9qn1 | Lab E | Community |
| 23 May 2026 | PE 22-28 | 6.0 A | 50mg | 61.0mg | +22.0% | 97.85% | 77oteo | Lab D | Public |
| 23 May 2026 | Semax | 6.8 A | 50mg | 47.2mg | -5.6% | 96.48% | haev5s | Lab D | Public |
| 23 May 2026 | Tirzepatide Raw | 4.3 C | 500g | 600.8g | +20.2% | 95.65% | usay4q | Lab F | Public |
| 23 May 2026 | Trenbolone Acetate | 7.7 A | 200mg/ml | 201.2mg/ml | +0.6% | 98.04% | in8rj5 | Lab E | Public |
| 21 May 2026 | Retatrutide | 8.1 A | 15mg | 17.2mgpackage | 18.6mg | +8.4% | 99.80% | 2025B53-11 | Clear Label / Silver Crimp / Black Cap |
| 21 May 2026 | Boldenone Undecylenate (EQ) Raw | 7.2 A | 1g | 1.2g | +19.7% | 95.25% | 3wsots | Lab G | Community |
| 21 May 2026 | P21 | 5.8 B | 2mg | 1.9mg | -3.3% | 95.12% | hghunb | Lab F | Community |
| 21 May 2026 | GHRP-2 Acetate | 6.3 A | 20mg | 23.8mg | +18.9% | 99.37% | lsejol | Lab D | Public |
| 21 May 2026 | Oxytocin Acetate | 6.6 A | 10mg | 10.3mg | +3.2% | 95.30% | tpks6u | Lab G | Public |
| 21 May 2026 | T4 (Levothyroxine) | 6.7 A | 10mg | 10.3mg | +3.0% | 99.39% | qh5xp9 | Lab E | Community |
| 20 May 2026 | Boldenone Undecylenate (EQ) Raw | 5.6 B | 5g | 4.8g | -4.4% | 95.01% | 2soqh5 | Lab F | Public |
| 19 May 2026 | BPC157 10mg + TB500 10mg Blend | 5.3 B | 2mg | 2.3mg | +16.9% | 96.97% | qe99bk | Lab A | Community |
| 19 May 2026 | Bronchogen | 8.9 A | 20mg | 21.1mg | +5.6% | 97.39% | twol5a | Lab D | Community |
| 19 May 2026 | Drostanolone Enanthate (Mast E) Raw | 6.6 A | 1g | 1.2g | +20.9% | 99.01% | mgg4bb | Lab A | Public |
| 19 May 2026 | Semax | 4.8 C | 5mg | 4.3mg | -13.1% | 98.77% | 6mwadu | Lab F | Public |
| 17 May 2026 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 5.8 B | 100g | 124.4g | +24.4% | 98.03% | 4229db | Lab E | Public |
| 17 May 2026 | BPC157 5mg + TB500 5mg Blend | 6.7 A | 50mg | 53.5mg | +7.0% | 95.71% | pdgon4 | Lab F | Public |
| 17 May 2026 | Hyaluronic acid | 5.9 B | 10mg | 8.7mg | -13.2% | 98.62% | c1t8k8 | Lab C | Public |
| 17 May 2026 | KPV Oral | 4.0 C | 10mg | 11.1mg | +11.1% | 95.07% | z019rd | Lab G | Public |
| 17 May 2026 | Ostarine (MK-2866) | 6.3 A | 50mg | 46.1mg | -7.8% | 99.49% | 196jap | Lab F | Public |
| 29 Jan 2026 | ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 | 6.1 A | 5g | 6.1g | +22.2% | 96.30% | yru1ig | Lab F | Public |
| 29 Jan 2026 | Superdrol | 4.2 C | 10mg | 10.8mg | +8.1% | 99.89% | 6q4ub2 | Lab F | Public |
| 26 Jan 2026 | Retatrutide | 8.5 A | 15mg | 17.2mgpackage | 15.9mg | -7.3% | 99.80% | 2025B53-11 | No Label / Silver Crimp / Black Cap |
| 26 Jan 2026 | Tirzepatide | 7.3 A | 30mg | (no batch claim) | 35.3mg | +17.7% | 99.90% | 2025A56-10 | No Label / Silver Crimp / Orange Cap |
| 26 Jan 2026 | Cardiogen | 6.9 A | 10mg | 10.1mg | +0.8% | 95.66% | sdgvxm | Lab B | Public |
| 26 Jan 2026 | EPO | 5.6 B | 30mg | 25.6mg | -14.6% | 98.42% | f7ldca | Lab G | Community |
| 26 Jan 2026 | Orforglipron | 4.5 C | 25mg | 29.5mg | +17.9% | 98.93% | 4ui1ol | Lab D | Community |
| 26 Jan 2026 | Super Shred | 9.0 A | 100mg/ml | 95.4mg/ml | -4.6% | 99.37% | zmaitx | Lab F | Community |
| 19 Jan 2026 | Retatrutide | 6.8 B | 50mg | 57.4mgpackage | 47.1mg | -18.0% | 99.95% | 2025B510-10 | No Label / Green Crimp / Clear Cap |
| 19 Jan 2026 | FOXO4 | 6.5 A | 2mg | 1.8mg | -8.8% | 99.38% | 2xlhuu | Lab F | Public |
| 7 Jan 2026 | Hyaluronic acid | 7.1 A | 30mg | 25.6mg | -14.5% | 96.92% | 2cgm4y | Lab B | Public |
| 7 Jan 2026 | P21 | 5.2 B | 30mg | 26.8mg | -10.7% | 99.75% | z8khbj | Lab D | Public |
| 7 Jan 2026 | Thymalin | 6.0 A | 30mg | 33.3mg | +11.0% | 98.40% | hplpiz | Lab C | Public |
| 7 Jan 2026 | YK-11 Raw | 6.7 A | 10g | 9.9g | -1.2% | 99.55% | 94ijiq | Lab E | Public |
| 29 Dec 2025 | Trenbolone Enanthate | 8.8 A | 100mg/ml | 110.4mg/ml | +10.4% | 96.52% | oakv3m | Lab B | Community |
| 29 Dec 2025 | YK-11 Raw | 5.6 B | 100g | 112.8g | +12.8% | 97.63% | sudsmk | Lab C | Public |
| 12 Dec 2025 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 5.9 B | 10g | 12.1g | +21.5% | 97.02% | 9z7x14 | Lab C | Community |
| 5 Dec 2025 | EPO | 6.0 A | 30mg | 28.3mg | -5.6% | 97.98% | fyantd | Lab G | Public |
| 23 Nov 2025 | Orforglipron | 5.0 B | 50mg | 50.4mg | +0.7% | 97.57% | 8cx9ah | Lab F | Public |
| 17 Nov 2025 | Estradiol Cypionate | 6.2 A | 100mg/ml | 93.9mg/ml | -6.1% | 95.52% | bs95qf | Lab G | Public |
| 5 Nov 2025 | FOXO4 | 6.3 A | 50mg | 50.7mg | +1.3% | 97.90% | ekl9n8 | Lab D | Community |
| 4 Nov 2025 | AICAR | 4.2 C | 10mg | 11.5mg | +14.6% | 98.26% | zjfie2 | Lab F | Public |
| 4 Nov 2025 | Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) | 6.0 A | 200mg/ml | 211.1mg/ml | +5.6% | 96.58% | hbwkr6 | Lab A | Public |
| 4 Nov 2025 | Proviron (Mesterolone) | 7.6 A | 50mg | 51.5mg | +3.0% | 95.02% | 0x1s90 | Lab B | Public |
| 17 Oct 2025 | Cartalax | 4.0 C | 5mg | 4.9mg | -1.2% | 99.29% | fcfqj8 | Lab C | Community |
| 17 Oct 2025 | Proviron (Mesterolone) | 7.1 A | 50mg | 43.1mg | -13.7% | 95.54% | 2aemno | Lab G | Public |
| 9 Oct 2025 | Oxytocin Acetate | 6.3 A | 30mg | 35.7mg | +19.1% | 97.24% | aglgwp | Lab A | Public |
| 9 Oct 2025 | T4 (Levothyroxine) | 6.7 A | 25mg | 27.1mg | +8.5% | 98.58% | bddddk | Lab B | Community |
| 3 Oct 2025 | Anastrozole (Arimidex) Raw | 4.0 C | 10g | 10.7g | +6.8% | 96.36% | clb44k | Lab B | Community |
— END OF EVIDENCE LOG —